Organised by the publishers of NutraIngredients, in partnership with the International Probiotics Association (IPA), the IPA World Congress + Probiota 2018 will combine the latest insights from science, regulation and business to provide delegates with the ultimate event to bridge the gap between the worlds of business and scientific research.
Moving to Barcelona for its 2018 edition, the congress will explore the frontier of prebiotic, probiotic and microbiome science, and how that is applied in the commercial world for food and nutraceutical players everywhere.
After months of searching, and sifting through abstracts submitted late last year, our Scientific Committee has settled on three winners of the Probiota Scientific Frontiers sessions.
The three top abstracts will be presented to more than 300 delegates – made up of leading academics and top international executives from companies working in the related fields of probiotics, prebiotics and the microbiome – in a special session hosted by NutraIngredients Science Editor, Will Chu, at the IPA World Congress + Probiota 2018.
The three winning abstracts are:
- Anna Happel, University of Cape Town
Presenting on: Vaginal versus commercially available probiotic Lactobacillus spp. for vaginal health
- Serge Gouin, Université de Montréal
Presenting on: Probiotic Regimen for Outpatient Gastroenteritis – Utility of Treatment (PROGUT) Study: A Multicenter Randomized Controlled Trial
- Vasiliki Kachrimanidou, University of Reading
Presenting on: An in-vitro evaluation of different carbohydrates on the selective fermentation of Lactobacillus rhamnosus ATCC 53103
A further group of selected abstracts will be presented as posters as part of the Probiota Scientific Frontiers: Poster Sessions.
IPA World Congress + Probiota 2018: The Agenda
The three day festival of science and business will run between February 7 – 9th in Barcelona, Spain. On the agenda this year are engaging sessions on modulating the microbiome for sports performance, consumer understanding of pre- and probiotics, the importance of the microbiota in the first 1000 days of life, plus sessions looking at the latest microbiome start-up trailblazers and targeting diseases through the microbiome.
In addition, don’t miss key updates from the IPA and dynamic panel discussions will look at regulatory challenges in the microbiome space and how personalised nutrition and wearable devices are starting to alter the direction of research methodologies and business plans.
Check out the full program breakdown here. Spots for the Congress are filling up fast, so be sure to register for your place soon!